Drug Type Small molecule drug |
Synonyms BR102910 |
Target |
Action antagonists |
Mechanism FAP antagonists(Fibroblast activation protein alpha antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H14Cl2F2N4O2S |
InChIKeyJTSUDVSZJDOOJG-NSHDSACASA-N |
CAS Registry2505339-54-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | South Korea | 01 Apr 2021 | |
Diabetes Mellitus, Type 2 | Preclinical | South Korea | 01 Apr 2021 |